EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis

Guangfu Xu, Ling Zhang, Fei Li iD, Wenwen Han, Hailong Sun, Jiangtao Cao iD

Canadian Respiratory Journal · 2025

DOI: 10.1155/carj/5575392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Respiratory Journal, 2025. Verfasst von Guangfu Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, MicroRNAs, Lung Neoplasms, HSP90 Heat-Shock Proteins. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to explore the potential of LINC01214 in providing prognostic and therapeutic insights, thereby offering valuable references for the research of non‐small cell lung cancer (NSCLC).

Methods

122 NSCLC subjects were recruited. The molecular level was quantified by qPCR and WB. Kaplan–Meier estimated the prognostic effects and Cox regression analyses the hazard ratio. The cell activities including proliferation, apoptosis, and migration/invasion were evaluated by CCK‐8, flow cytometry, and Transwell. The regulatory axis of LINC01214/miR‐497‐3p/HSP90AB1 was verified by the dual luciferase reporter assay and rescue experiments.

Results

LINC01214 increased both in the malignant tissues and cell lines of NSCLC. Mortality was increased in NSCLC patients with high LINC01214 levels. LINC01214 was an independent risk predictor of prognosis in NSCLC. Silencing of LINC01214 inhibited the NSCLC cell proliferation, migration, and invasion and promoted apoptosis. The abundance of miR‐497‐3p showed an opposite trend to LINC01214. LINC01214 could target miR‐497‐3p and negatively correlate with miR‐497‐3p. The inhibitory effect of LINC01214 on cell activity was reversed by miR‐497‐3p. HSP90AB1 was predicted and further confirmed as the target of miR‐497‐3p. The LINC01214/miR‐497‐3p/HSP90AB1 axis regulated NSCLC cell proliferation, migration, and invasion.

Conclusion

LINC01214, a potential biomarker, contributed to the progression of NSCLC through the miR‐497‐3p/HSP90AB1 axis by promoting cell proliferation and motility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungMicroRNAsLung NeoplasmsHSP90 Heat-Shock ProteinsRNA, Long NoncodingHumansMaleFemaleCell ProliferationMiddle AgedCell MovementApoptosisPrognosisCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

HSP90AB1NSCLClncRNA LINC01214miR-497-3p

Substanzen

MicroRNAsHSP90 Heat-Shock ProteinsRNA, Long NoncodingMIRN497 microRNA, humanHSP90AB1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
  • Department of Pulmonary and Critical Care Medicine, The People's Hospital of Dadukou District Chongqing, Chongqing 400084, China.
  • Department of Medical Imaging, Dongying People's Hospital, Dongying 257091, China.
  • Department of Respiratory and Critical Care Medicine, First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.

ORCID-Profile: Fei Li, Jiangtao Cao

Zitieren

APA

Xu, G., Zhang, L., Li, F., Han, W., Sun, H., & Cao, J. (2025). LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis. Canadian Respiratory Journal. https://doi.org/10.1155/carj/5575392

Vancouver

Xu G, Zhang L, Li F, Han W, Sun H, Cao J. LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis. Canadian Respiratory Journal. 2025. doi:10.1155/carj/5575392

BibTeX
@article{Xu2025,
  author = {Xu, Guangfu and Zhang, Ling and Li, Fei and Han, Wenwen and Sun, Hailong and Cao, Jiangtao},
  title = {LINC01214 Promotes Non‐Small Cell Lung Cancer Through the miR‐497‐3p/HSP90AB1 Axis},
  journal = {Canadian Respiratory Journal},
  year = {2025},
  doi = {10.1155/carj/5575392}
}
Kostenlos starten →